Translational Therapeutics

Translational Therapeutics Program Specific Aims

Aim 1.     Identify genomic and signaling pathway alterations in solid tumors for the development of targeted therapeutics.

Aim 2.     Identify targetable tumor-host interactions mediated by macromolecules and extracellular vesicles

Aim 3.     Develop biomarkers in solid tumors for prognosis and selection of therapy

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu